Studies Peptides Calculator

Pepdox aggregates peer-reviewed research from PubMed. This site is for informational purposes only.

Built by Thorne

Glossary Privacy Policy

Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss. | Pepdox

Home
Search
PMID 42139026

Orforglipron (Foundayo) - a second oral GLP-1 receptor agonist for weight loss.

The Medical letter on drugs and therapeutics2026PMID: 42139026

View on PubMed DOI: 10.58347/tml.2026.1755a

Keywords

FoundayoWegovyadverse effectsdosagedrug interactionsefficacylactationorforglipronpregnancysafetysemaglutideweight loss